nhtsa - unece.org · • develop and validate 3-d cervical spine kinematic instrumentation •...
TRANSCRIPT
![Page 1: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/1.jpg)
GTR 7 Informal Working GroupDecember 5, 2011
Geneva
Preliminary PMHS Injury Risk Curves & Potential IARVs in Rear Impact ____________________________
Preliminary PMHS Injury Risk Curves & Potential IARVs in Rear Impact____________________________
Kevin Moorhouse, Ph.D.NHTSA
Yun-Seok Kang, Ph.D.Ohio State University
Kevin Moorhouse, Ph.D.NHTSA
Yun-Seok Kang, Ph.D.Ohio State University
![Page 2: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/2.jpg)
Rear Impact Research ObjectivesRear Impact Research Objectives
• Evaluate biofidelity of available RIDs (BioRID, RID3D, HyIII)• Choose biofidelity test condition• Develop experimental seat for rear impact sled testing• Conduct sled tests
• PMHS (Post-Mortem Human Subjects)• Dummies (BioRID II, RID3D, Hybrid III)
• Assess biofidelity and repeatability of dummies
• Investigate the mechanism of injury• Develop and validate 3-D cervical spine kinematic instrumentation• Identify injurious kinematics
• Choose appropriate injury criterion• Assess efficacy of various ICs
• Evaluate biofidelity of available RIDs (BioRID, RID3D, HyIII)• Choose biofidelity test condition• Develop experimental seat for rear impact sled testing• Conduct sled tests
• PMHS (Post-Mortem Human Subjects)• Dummies (BioRID II, RID3D, Hybrid III)
• Assess biofidelity and repeatability of dummies
• Investigate the mechanism of injury• Develop and validate 3-D cervical spine kinematic instrumentation• Identify injurious kinematics
• Choose appropriate injury criterion• Assess efficacy of various ICs
![Page 3: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/3.jpg)
Rear Impact Injury MechanismRear Impact Injury Mechanism
![Page 4: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/4.jpg)
Documentation of Injuries
![Page 5: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/5.jpg)
C7/T1
C3/C4
C4/C5
C7/T1
<CT sagittal view>
<Disc rupture w fracture>
<Facet joint>
Injury Examples (Post-test CT) Injury Examples (Post-test CT)
![Page 6: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/6.jpg)
C1
C2
C3
C4
C5
C6
C7
T1
C7
T1
C6
C5
C2
<posterior view>
<lateral view>
anterior longitudinal
ligament
ligamentum flavum
facet joint capsule
interspinous ligamentC4
C3
<posterior view>
: disc rupture : subluxation: laceration (tear)
PMHS03PMHS04PMHS05PMHS06PMHS07PMHS08
Documentation of InjuriesDocumentation of Injuries
![Page 7: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/7.jpg)
PMHS #1 #2 #3 #4 #5 #6 #7 #8
C2/C3 No injury No injury No injury No injurySubluxation bilateral@ FJ
(AIS3)No injury No injury No injury
C3/C4 No injury No injurySubluxation bilateral@
FJ (AIS3)No injury
Subluxation bilateral@ FJ
(AIS3) and ligametum
flavum (AIS1)No injury No injury No injury
C4/C5 No injury No injurySubluxation bilateral@
FJ (AIS3)Subluxation bilateral@
FJ (AIS3)Subluxation bilateral@ FJ
(AIS3)No injury
Subluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous
lig(AIS1)
No injury
C5/C6 No injury No injury No injury
Subluxation bilateral@
FJ (AIS3) and ligametum
flavum/interspinous
lig(AIS1)
Subluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous
lig(AIS1)
Facet joint capsule tear
on right side/
degeneration disc‐mild
subluxation (AIS1)
No injury No injury
C6/C7 No injury No injury No injury
Subluxation bilateral@
ligamentum flavum
(AIS1) & interspinous lig
(AIS1)
Subluxation @ Interspinous
lig (AIS1)No injury
Anterior longitudinal lig
tear (posterior intact),
Severe Subluxation @ FJ
on both sides, ligamentum
flavum tear, Disc injury w
ruptured (AIS3),
Interspinous lig tear (AIS1)
Seperation of
degenerative disc,
ligamentum flavum tear
@ right side close to
spinous process, facet
joint capsule tear on the
right side (AIS1)
C7/T1 No injury No injury
Anterior longitudinal lig.
tear (posterior intact), FJ
capsule tear on both
sides, ligamentum
flavum tear on left side,
Disc rupture w fracture
(AIS3), Interspinous lig.
tear (AIS1)
Seperation of
degenerative discNo injury No injury No injury No injury
Documentation of InjuriesDocumentation of Injuries
![Page 8: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/8.jpg)
Injury Criteria Analysis
![Page 9: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/9.jpg)
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
C1
C2
C3
C4
C5
C6
C7
T1
Injuries @ intervertebral levelsInjuries @ intervertebral levels
Inte
rver
tebr
al k
inem
atic
sIn
terv
erte
bral
kin
emat
ics
Injury Risk Curves
•• C2/C3 C2/C3 –– C6/C7: 5 levelsC6/C7: 5 levels•• 5 data points per test5 data points per test•• Two speedsTwo speeds•• n ~ 10 per subject n ~ 10 per subject
0
1
1
0
0
![Page 10: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/10.jpg)
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Peudo R2 > 0.2, Nagelkerke R2 > 0.4, P-value < 0.05 , Goodman-Kruskal Gamma > 0.6
Best correlation and prediction
Intervertebral kinematics Pseudo R2 Nagelkerke R2 Log-Likelihood P-value Goodman-Kruskal Gamma
Acceleration x(+) 0.05 0.08 -30.377 0.067 0.49(-) 0.17 0.25 -26.744 0.001 0.72Max 0.09 0.14 -29.142 0.016 0.59
Acceleration z(+) 0.17 0.26 -26.584 0.001 0.62(-) 0.10 0.15 -28.963 0.013 0.59Max 0.12 0.19 -28.179 0.005 0.58
Velocity x(+) 0.04 0.07 -30.612 0.089 0.34(-) 0.20 0.29 -25.785 0.000 0.54Max 0.20 0.29 -25.797 0.000 0.54
Velocity z(+) 0.01 0.01 -31.855 0.527 -0.05(-) 0.12 0.18 -28.31 0.006 0.47Max 0.04 0.06 -30.908 0.130 0.14
Angular velocity y(+) 0.30 0.43 -20.696 0.000 0.83(-) 0.05 0.08 -33.195 0.074 0.42Max 0.17 0.26 -28.837 0.001 0.7
Displacement x Max 0.11 0.17 -29.93 0.008 0.41Displacement z Max 0.29 0.41 -23.76 0.000 0.69Rotation y Max 0.72 0.83 -8.236 0.000 0.96
(+) : positive peak, (-): negative peak, Max: maximum peak
![Page 11: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/11.jpg)
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Peudo R2 > 0.2, Nagelkerke R2 > 0.4, P-value < 0.05 , Goodman-Kruskal Gamma > 0.6
Best correlation and prediction
Intervertebral kinematics Pseudo R2 Nagelkerke R2 Log-Likelihood P-value Goodman-Kruskal Gamma
Acceleration x(+) 0.05 0.08 -30.377 0.067 0.49(-) 0.17 0.25 -26.744 0.001 0.72Max 0.09 0.14 -29.142 0.016 0.59
Acceleration z(+) 0.17 0.26 -26.584 0.001 0.62(-) 0.10 0.15 -28.963 0.013 0.59Max 0.12 0.19 -28.179 0.005 0.58
Velocity x(+) 0.04 0.07 -30.612 0.089 0.34(-) 0.20 0.29 -25.785 0.000 0.54Max 0.20 0.29 -25.797 0.000 0.54
Velocity z(+) 0.01 0.01 -31.855 0.527 -0.05(-) 0.12 0.18 -28.31 0.006 0.47Max 0.04 0.06 -30.908 0.130 0.14
Angular velocity y(+) 0.30 0.43 -20.696 0.000 0.83(-) 0.05 0.08 -33.195 0.074 0.42Max 0.17 0.26 -28.837 0.001 0.7
Displacement x Max 0.11 0.17 -29.93 0.008 0.41Displacement z Max 0.29 0.41 -23.76 0.000 0.69Rotation y Max 0.72 0.83 -8.236 0.000 0.96Facet JT Slide Max 0.38 0.52 -18.5276 0.000 0.77Facet JT Slide Rate Max 0.13 0.20 -30.388 0.003 0.49Facet JT Axial Max 0.06 0.10 -32.7106 0.041 0.28Facet JT Axial Rate Max 0.05 0.09 -32.953 0.055 0.38(+) : positive peak, (-): negative peak, Max: maximum peak
![Page 12: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/12.jpg)
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Peudo R2 > 0.2, Nagelkerke R2 > 0.4, P-value < 0.05 , Goodman-Kruskal Gamma > 0.6
Best correlation and prediction
Intervertebral kinematics Pseudo R2 Nagelkerke R2 Log-
Likelihood P-valueGoodman-
Kruskal Gamma
Rotation y Max 0.72 0.83 -8.236 0.000 0.96
Angular velocity y (+) 0.30 0.43 -20.696 0.000 0.83
Facet JT Slide Max 0.38 0.52 -18.5276 0.000 0.77
(+) : positive peak, (-): negative peak, Max: maximum peak
![Page 13: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/13.jpg)
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Injury Analysis Injury Risk Curves – Intervertebral Kinematics
Facet Slide
Intervertebral Angular Velocity
Intervertebral Rotation
•• Each intervertebral level may have Each intervertebral level may have different thresholddifferent threshold
•• Normalization using physiological Normalization using physiological range of motionrange of motion
•• IVIV--NIC [Panjabi et al., 1999] NIC [Panjabi et al., 1999]
![Page 14: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/14.jpg)
IV‐NIC (Rotation)PMHS03 PMHS04 PMHS05 PMHS06 PMHS07 PMHS08
Low Moderate Low Moderate Low Moderate Low Moderate Low Moderate Low Moderate
C2/C3‐0.85 ‐0.79 ‐1.06** ‐0.87 ‐1.84 ‐1.52 ‐0.40 ‐0.49 ‐0.90 ‐0.99 ‐0.34 ‐0.45
+0.26 +0.67 +0.17 +0.26 0.46 0.86 0.23 +0.41 +0.21 +0.30 +0.04 +0.19
C3/C4‐1.18 ‐1.07 ‐0.27 ‐0.41 ‐1.59 ‐1.54 ‐0.09 ‐0.07 ‐0.87 ‐1.00 ‐0.68 ‐0.90
+0.48 +1.05 +1.02** +0.51 +0.05 +0.18 +0.54 +0.94 +0.15 +0.10 +0.19 +0.28
C4/C5‐1.47 ‐1.87 ‐1.17 ‐1.40 ‐1.37 ‐1.16 ‐0.13 ‐0.19 ‐1.48 ‐1.44 ‐0.54 ‐0.79
+0.01 +0.01 +0.00 +0.00 +0.00 +0.05 +0.39 +0.62 +0.05 +0.09 +0.05 +0.10
C5/C6‐0.56 ‐0.40 ‐0.96 ‐1.00 ‐1.08 ‐1.19 ‐0.09 ‐0.09 ‐0.85 ‐0.91 ‐0.69 ‐0.69
+0.27 +0.30 +0.00 +0.01 +0.01 +0.00 +0.36 +1.00 +0.00 0.00 +0.00 +0.50
C6/C7
‐0.33 ‐0.54 ‐1.15 ‐1.33 ‐0.84 ‐1.20 ‐0.16 ‐0.16 ‐0.72 ‐0.73 ‐0.79 ‐1.05
+0.05 +0.68 +0.00 +0.00 +0.44 +0.20 +0.05 +0.47 +0.06 +1.69 +0.00 +0.35
C7/T1
‐0.61 ‐0.73 ‐0.80 ‐0.68 ‐0.69 ‐0.56 ‐0.48 ‐0.32 ‐0.73 ‐0.76 ‐0.89 ‐1.16
+0.19 +3.79 +0.00 +1.93 +0.81 +0.90 +0.10 +0.96 +0.84 +1.86 0.05 1.54
Qualitative Correlation -IV-NIC and Injuries
Qualitative Correlation -IV-NIC and Injuries
![Page 15: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/15.jpg)
Qualitative Correlation -IV-NIC and Injuries
Qualitative Correlation -IV-NIC and Injuries
Injury DocumentationPMHS03 PMHS04 PMHS05 PMHS06 PMHS07 PMHS08
C2/C3 No injury No injury Subluxation bilateral@ FJ (AIS3) No injury No injury No injury
C3/C4 Subluxation bilateral@ FJ
(AIS3)No injury
Subluxation bilateral@ FJ (AIS3)
and ligametum flavumNo injury No injury No injury
C4/C5 Subluxation bilateral@ FJ
(AIS3)Subluxation bilateral@ FJ
(AIS3)Subluxation bilateral@ FJ (AIS3) No injury
Subluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous lig.No injury
C5/C6 No injurySubluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous lig.
Subluxation bilateral@ FJ (AIS3)
and ligametum
flavum/interspinous lig.
Facet joint capsule tear on
right side/ degeneration disc‐
mild subluxationNo injury No injury
C6/C7 No injurySubluxation bilateral@
ligamentum flavum &
interspinous lig.Subluxation @ Interspinous lig No injury
Anterior longitudinal lig. tear
(posterior intact), Severe
Subluxation @ FJ on both
sides, ligamentum flavum
tear, Disc injury w ruptured
(AIS3), Interspinous lig. tear
(AIS1)
Seperation of degenerative
disc, ligamentum flavum
tear @ right side close to
spinous process, facet joint
capsule tear on the right
side
C7/T1
Anterior longitudinal lig.
tear (posterior intact), FJ
capsule tear on both sides,
ligamentum flavum tear on
left side, Disc injury w
ruptured (AIS3),
Interspinous lig. tear (AIS1)
Seperation of degenerative
discNo injury No injury No injury No injury
![Page 16: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/16.jpg)
IV‐NIC (Rotation)PMHS03 PMHS04 PMHS05 PMHS06 PMHS07 PMHS08
Low Moderate Low Moderate Low Moderate Low Moderate Low Moderate Low Moderate
C2/C3‐0.85 ‐0.79 ‐1.06** ‐0.87 ‐1.84 ‐1.52 ‐0.40 ‐0.49 ‐0.90 ‐0.99 ‐0.34 ‐0.45
+0.26 +0.67 +0.17 +0.26 0.46 0.86 0.23 +0.41 +0.21 +0.30 +0.04 +0.19
C3/C4‐1.18 ‐1.07 ‐0.27 ‐0.41 ‐1.59 ‐1.54 ‐0.09 ‐0.07 ‐0.87 ‐1.00 ‐0.68 ‐0.90
+0.48 +1.05 +1.02** +0.51 +0.05 +0.18 +0.54 +0.94 +0.15 +0.10 +0.19 +0.28
C4/C5‐1.47 ‐1.87 ‐1.17 ‐1.40 ‐1.37 ‐1.16 ‐0.13 ‐0.19 ‐1.48 ‐1.44 ‐0.54 ‐0.79
+0.01 +0.01 +0.00 +0.00 +0.00 +0.05 +0.39 +0.62 +0.05 +0.09 +0.05 +0.10
C5/C6‐0.56 ‐0.40 ‐0.96 ‐1.00 ‐1.08 ‐1.19 ‐0.09 ‐0.09 ‐0.85 ‐0.91 ‐0.69 ‐0.69
+0.27 +0.30 +0.00 +0.01 +0.01 +0.00 +0.36 +1.00 +0.00 0.00 +0.00 +0.50
C6/C7
‐0.33 ‐0.54 ‐1.15 ‐1.33 ‐0.84 ‐1.20 ‐0.16 ‐0.16 ‐0.72 ‐0.73 ‐0.79 ‐1.05
+0.05 +0.68 +0.00 +0.00 +0.44 +0.20 +0.05 +0.47 +0.06 +1.69 +0.00 +0.35
C7/T1
‐0.61 ‐0.73 ‐0.80 ‐0.68 ‐0.69 ‐0.56 ‐0.48 ‐0.32 ‐0.73 ‐0.76 ‐0.89 ‐1.16
+0.19 +3.79 +0.00 +1.93 +0.81 +0.90 +0.10 +0.96 +0.84 +1.86 0.05 1.54
Qualitative Correlation -IV-NIC and Injuries
Qualitative Correlation -IV-NIC and Injuries
![Page 17: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/17.jpg)
Qualitative Correlation -IV-NIC and Injuries
Qualitative Correlation -IV-NIC and Injuries
Injury DocumentationPMHS03 PMHS04 PMHS05 PMHS06 PMHS07 PMHS08
C2/C3 No injury No injury Subluxation bilateral@ FJ (AIS3) No injury No injury No injury
C3/C4 Subluxation bilateral@ FJ
(AIS3)No injury
Subluxation bilateral@ FJ (AIS3)
and ligametum flavumNo injury No injury No injury
C4/C5 Subluxation bilateral@ FJ
(AIS3)Subluxation bilateral@ FJ
(AIS3)Subluxation bilateral@ FJ (AIS3) No injury
Subluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous lig.No injury
C5/C6 No injurySubluxation bilateral@ FJ
(AIS3) and ligametum
flavum/interspinous lig.
Subluxation bilateral@ FJ (AIS3)
and ligametum
flavum/interspinous lig.
Facet joint capsule tear on
right side/ degeneration disc‐
mild subluxationNo injury No injury
C6/C7 No injurySubluxation bilateral@
ligamentum flavum &
interspinous lig.Subluxation @ Interspinous lig No injury
Anterior longitudinal lig. tear
(posterior intact), Severe
Subluxation @ FJ on both
sides, ligamentum flavum
tear, Disc injury w ruptured
(AIS3), Interspinous lig. tear
(AIS1)
Seperation of degenerative
disc, ligamentum flavum
tear @ right side close to
spinous process, facet joint
capsule tear on the right
side
C7/T1
Anterior longitudinal lig.
tear (posterior intact), FJ
capsule tear on both sides,
ligamentum flavum tear on
left side, Disc injury w
ruptured (AIS3),
Interspinous lig. tear (AIS1)
Seperation of degenerative
discNo injury No injury No injury No injury
![Page 18: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/18.jpg)
Injury Analysis Injury Risk Curves – IV-NIC parameters
Injury Analysis Injury Risk Curves – IV-NIC parameters
Peudo R2 > 0.2, Nagelkerke R2 > 0.4, P-value < 0.05 , Goodman-Kruskal Gamma > 0.6
Best correlation and prediction
Intervertebral kinematics Pseudo R2 Nagelkerke R2 Log-Likelihood P-valueGoodman-
Kruskal Gamma
IV-NICs (slide) Max 0.19 0.30 -23.912 0.001 0.58
IV-NICs rate Max 0.10 0.17 -26.555 0.013 0.44
IV-NICs product Max 0.16 0.25 -24.824 0.002 0.57
IV-NICa (axial) Max 0.01 0.02 -29.212 0.350 0.17
IV-NICa rate Max 0.004 0.007 -29.526 0.621 0.15
IV-NICa product Max 0.005 0.009 -29.493 0.578 0.23
IV-NICu Max 0.74 0.84 -8 0.000 0.95
IV-NICu rate Max 0.10 0.15 -26.723 0.016 0.59
IV-NICu product Max 0.40 0.55 -17.677 0.000 0.83
(+) : positive peak, (-): negative peak, Max: maximum peak
![Page 19: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/19.jpg)
Injury Analysis Injury Risk Curves – IV-NIC parameters
Injury Analysis Injury Risk Curves – IV-NIC parameters
•• Each intervertebral level was normalized by physiological range Each intervertebral level was normalized by physiological range of motionsof motions•• IVIV--NICu : best correlation to injuriesNICu : best correlation to injuries
•• IVIV--NICu product: also shows correlationNICu product: also shows correlation•• 50 % chance of AIS 1+ injuries50 % chance of AIS 1+ injuries
•• IVIV--NICu : 1.12 NICu : 1.12 •• IVIV--NICu product : 132.58 NICu product : 132.58
![Page 20: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/20.jpg)
Current/Potential Injury Criteria
Current/Potential Injury Criteria
• Correlation between IV-NIC values and existing injury criteria• Correlation between IV-NIC values and existing injury criteria
Correlation?
Yes
NDC, NijHead-to-T1 RotationUpper/Lower Fx, Fz, MyT1GRebound VAny physical parameters
22.0 relrel vaNIC +×=
intint MM
FFN yx
km +=
tension
lower
shear
lowerlower
moment
lowerlower
CtFz
CtFytFx
CtMxtMy
tindexLNL
)()()(
)()()(
++
+
+=−
22
22
Potential PMHS IARVs
uNICIV −
( )productuNICIV −
![Page 21: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/21.jpg)
Current/Potential Injury Criteria
Current/Potential Injury Criteria
x
z
xzRelativeOC-to-T1 velocity
1
IV-N
IC a
nd IV
-NIC
pr
oduc
t
Correlation?Correlation?
Occipital Condyle (OC)
1st thoracic vertebra (T1)
![Page 22: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/22.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
IV-NICu IV-NICu productR - value P - value R - value P - value
NIC 0.685 0 0.714 0Nte 0.356 0.011 0.419 0.002Ntf 0.68 0 0.659 0Nce 0.208 0.147 0.332 0.018Ncf 0.698 0 0.661 0Nae 0.25 0.08 0.353 0.012Naf 0.169 0.24 0.257 0.072Npe 0.018 0.899 0.121 0.402Npf 0.305 0.031 0.359 0.011LNL 0.285 0.045 0.349 0.013NDCx 0.72 0 0.687 0NDCx rate 0.799 0 0.776 0NDCx product 0.809 0 0.778 0NDCz 0.694 0 0.758 0NDCz rate 0.604 0 0.701 0NDCz product 0.588 0 0.695 0NDCr 0.805 0 0.801 0NDCr rate 0.818 0 0.801 0NDCr product 0.818 0 0.81 0
Nij
Nkm
NDC
![Page 23: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/23.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCr• NDCr
![Page 24: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/24.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
IV-NICu IV-NICu productR - value P - value R - value P - value
NIC 0.685 0 0.714 0Nte 0.356 0.011 0.419 0.002Ntf 0.68 0 0.659 0Nce 0.208 0.147 0.332 0.018Ncf 0.698 0 0.661 0Nae 0.25 0.08 0.353 0.012Naf 0.169 0.24 0.257 0.072Npe 0.018 0.899 0.121 0.402Npf 0.305 0.031 0.359 0.011LNL 0.285 0.045 0.349 0.013NDCx 0.72 0 0.687 0NDCx rate 0.799 0 0.776 0NDCx product 0.809 0 0.778 0NDCz 0.694 0 0.758 0NDCz rate 0.604 0 0.701 0NDCz product 0.588 0 0.695 0NDCr 0.805 0 0.801 0NDCr rate 0.818 0 0.801 0NDCr product 0.818 0 0.81 0
Nij
Nkm
NDC
![Page 25: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/25.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCr• NDCr
![Page 26: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/26.jpg)
Injury Analysis Summary
Injury Analysis Summary
• Best injury predictor
• IV-NIC• Rotation more correlated than displacements
• IV-NIC product
• Current Injury Criteria• NIC, NDC
• NDCr more correlated than NDCx or NDCz
• Potential Injury Criteria• NDCr rate and product; NDCx rate and product
• Best injury predictor
• IV-NIC• Rotation more correlated than displacements
• IV-NIC product
• Current Injury Criteria• NIC, NDC
• NDCr more correlated than NDCx or NDCz
• Potential Injury Criteria• NDCr rate and product; NDCx rate and product
![Page 27: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/27.jpg)
Injury Criteria Analysis PlanInjury Criteria Analysis Plan
<PMHS> <BioRIDII>
PMHS and BioRID II in identical test conditions
Scaling technique for IARV(s)
Transfer function for IARV(s)
<Intervertebral rotation @ C4/C5>
![Page 28: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/28.jpg)
Injury Criteria Analysis PlanInjury Criteria Analysis Plan
• Plan for next meeting• Calculate intervertebral strain and strain rate
• Develop corresponding injury risk curves
• Detailed discussion and collaboration with Japan
• Develop most appropriate IARVs for PMHS
• Develop most appropriate IARVs for BioRID II
• Plan for next meeting• Calculate intervertebral strain and strain rate
• Develop corresponding injury risk curves
• Detailed discussion and collaboration with Japan
• Develop most appropriate IARVs for PMHS
• Develop most appropriate IARVs for BioRID II
![Page 29: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/29.jpg)
Thanks for your attentionThanks for your attention
Questions?Questions?
![Page 30: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/30.jpg)
![Page 31: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/31.jpg)
FBD for Lower Neck LoadsFBD for Lower Neck Loads
![Page 32: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/32.jpg)
• Intervertebral facet sliding rate (maximum peak)• Intervertebral facet sliding rate (maximum peak)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 33: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/33.jpg)
• Intervertebral facet axial rate (maximum peak)• Intervertebral facet axial rate (maximum peak)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 34: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/34.jpg)
• Intervertebral acceleration (positive peak x)• Intervertebral acceleration (positive peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 35: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/35.jpg)
• Intervertebral acceleration (negative peak x)• Intervertebral acceleration (negative peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 36: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/36.jpg)
• Intervertebral acceleration (maximum peak x)• Intervertebral acceleration (maximum peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 37: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/37.jpg)
• Intervertebral acceleration (positive peak z)• Intervertebral acceleration (positive peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 38: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/38.jpg)
• Intervertebral acceleration (negative peak z)• Intervertebral acceleration (negative peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 39: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/39.jpg)
• Intervertebral acceleration (maximum peak z)• Intervertebral acceleration (maximum peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 40: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/40.jpg)
• Intervertebral velocity (positive peak x)• Intervertebral velocity (positive peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 41: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/41.jpg)
• Intervertebral velocity (negative peak x)• Intervertebral velocity (negative peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 42: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/42.jpg)
• Intervertebral velocity (maximum peak x)• Intervertebral velocity (maximum peak x)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 43: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/43.jpg)
• Intervertebral velocity (positive peak z)• Intervertebral velocity (positive peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 44: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/44.jpg)
• Intervertebral velocity (negative peak z)• Intervertebral velocity (negative peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 45: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/45.jpg)
• Intervertebral velocity (maximum peak z)• Intervertebral velocity (maximum peak z)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 46: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/46.jpg)
• Intervertebral angular velocity (positive peak y)• Intervertebral angular velocity (positive peak y)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 47: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/47.jpg)
• Intervertebral angular velocity (negative peak y)• Intervertebral angular velocity (negative peak y)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 48: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/48.jpg)
• Intervertebral angular velocity (maximum peak y)• Intervertebral angular velocity (maximum peak y)
Additional Injury Risk CurvesAdditional Injury Risk Curves
![Page 49: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/49.jpg)
• Detailed cervical model • Detailed cervical model
Sagittal View from CT
PMHS0 1
PMHS04 PMHS05 PMHS07 PMHS08
Cervical Kinematics (detailed geometry)Cervical Kinematics (detailed geometry)
![Page 50: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/50.jpg)
• Detailed cervical model • able to calculate strain and strain rate between vertebrae
• Detailed cervical model • able to calculate strain and strain rate between vertebrae
correlation between strain/strain rate and injuries at each level
PMHS07
Cervical Kinematics (detailed geometry)Cervical Kinematics (detailed geometry)
![Page 51: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/51.jpg)
• Detailed cervical model • able to calculate strain and strain rate between vertebrae
• Detailed cervical model • able to calculate strain and strain rate between vertebrae
correlation between strain/strain rate and injuries at each level
PMHS07
Cervical Kinematics (detailed geometry)Cervical Kinematics (detailed geometry)
![Page 52: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/52.jpg)
Physiological Relative Rotation (Panjabi, 2005)
Physiological Flexion(-)/Extension(+)
Max valuesFlexion/Extension
C2/C3 -5.4(2.3)/+3.6(1.8) -7.7/+5.4
C3/C4 -5.7(2.7)/+4.2(1.9) -8.4/+6.1
C4/C5 -7.6(2.7)/+6.7(2.9) -10.3/+9.6
C5/C6 -7.7(4.5)/+6.5(3.5) -12.2/+10.0
C6/C7 -8.0(1.6)/+7.1(2.2) -9.6/+9.3
C7/T1 -3.7(1.6)/+3.1(1.1) -5.3/+4.2
calphysiologiΘΘ
=− traumaNICIV
IV-NIC CalculationIV-NIC Calculation
![Page 53: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/53.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NIC• NIC
![Page 54: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/54.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCx• NDCx
![Page 55: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/55.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCx rate• NDCx rate
![Page 56: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/56.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCx product• NDCx product
![Page 57: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/57.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCz• NDCz
![Page 58: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/58.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCz rate• NDCz rate
![Page 59: NHTSA - unece.org · • Develop and validate 3-D cervical spine kinematic instrumentation • Identify injurious kinematics • Choose appropriate injury criterion • Assess efficacy](https://reader033.vdocuments.us/reader033/viewer/2022041503/5e2302303da6162ab40fe45f/html5/thumbnails/59.jpg)
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
Injury Analysis IV-NIC vs. Current/Potential Injury Criteria
• NDCz product• NDCz product